Immediate Impact
69 standout
Citing Papers
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
Works of D.M. Scharn being referenced
Combination of the novel BET inhibitor BI 894999 with CDK9 inhibition suggests a promising regimen for the treatment of AML
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| D.M. Scharn | 47 | 51 | 4 | 21 | 6 | 85 | |
| Douglas R. Gibula | 64 | 36 | 56 | 7 | 90 | ||
| Manik Gemilyan | 75 | 20 | 10 | 42 | 7 | 184 | |
| Brian Gammon | 14 | 31 | 8 | 74 | 6 | 181 | |
| Joselyn Cerezo | 169 | 92 | 5 | 34 | 4 | 181 | |
| D Crimmins | 14 | 36 | 9 | 5 | 5 | 86 | |
| A. Prent | 72 | 64 | 56 | 7 | 182 | ||
| Ernst P. Boas | 41 | 25 | 2 | 63 | 9 | 192 | |
| R. Meerwaldt | 146 | 114 | 3 | 15 | 6 | 191 | |
| H. Vandamme | 101 | 139 | 40 | 7 | 164 | ||
| Marco Mota Gomes | 25 | 33 | 11 | 133 | 6 | 190 |
All Works
Loading papers...